Literature DB >> 15081350

Stability studies on diloxanide furoate: effect of pH, temperature, gastric and intestinal fluids.

E A Gadkariem1, F Belal, M A Abounassif, H A El-Obeid, K E E Ibrahim.   

Abstract

The degradation of the amoebicide diloxanide furoate in alkaline medium at different temperatures was investigated using both a spectrophotometric and a developed HPLC method. In solutions, the drug was found to undergo decomposition, i.e., temperature and pH dependent. The pH-rate profile at pH between 7.6 and 9.6 indicated a first-order dependence of Kobs on [-OH]. Arrhenius plot obtained at pH 8 was linear between 40 and 63 degrees C. The estimated activation energy of hydrolysis was found to be 18.25 kcal degree.mol(-1). The effect of simulated gastric and intestinal fluids on the drug was also investigated. A new thin-layer chromatographic (TLC) procedure for the fractionation of the drug and its alkaline hydrolysis products has been developed and was found to compare favorably with that of the British Pharmacopoeia. Three hydrolysis products of a basic methanolic solution of the drug, namely furoic acid, diloxanide and methylfuroate could be identified by the use of TLC, HPLC, infrared and mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081350     DOI: 10.1016/j.farmac.2003.11.015

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  3 in total

1.  In vitro susceptibility testing of Dientamoeba fragilis.

Authors:  N Nagata; D Marriott; J Harkness; J T Ellis; D Stark
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

2.  Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients.

Authors:  Robyn Nagel; Helle Bielefeldt-Ohmann; Rebecca Traub
Journal:  Gut Pathog       Date:  2014-08-20       Impact factor: 4.181

3.  Determination and stress studies on YK-1101, a potential histone deacetylase, by HPLC-UV and HPLC-TOF/MS methods.

Authors:  Chen Zhou; Wen-Yuan Liu; Feng Feng; Hai Ye; Chun-Yong Wu
Journal:  J Pharm Anal       Date:  2013-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.